THE REASONS OF RESISTANCE TO THE TNF α INHIBITORS AND WAYS OF ITS OVERCOMING

THE REASONS OF RESISTANCE TO THE TNF α INHIBITORS AND WAYS OF ITS OVERCOMING

Show other versions (1)

The article presents a review of literature data, dedicated to problems of secondary ineffectiveness of infliximab in patients with rheumatoid arthritis. An analysis of available data showed that the main reason of resistance to the TNF α inhibitors is a synthesis of antibodies to the drug. Risk fac...

Full description

Bibliographic Details
Main Authors:	E.I. Alexeeva, A.A. Grigor'eva, R.V. Denisova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2009-11-01
Series:	Вопросы современной педиатрии
Online Access:	https://vsp.spr-journal.ru/jour/article/view/1191

Similar Items

THE REASONS OF RESISTANCE TO THE TNF α INHIBITORS AND WAYS OF ITS OVERCOMING
by: E.I. Alexeeva, et al.
Published: (2009-01-01)

QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α
by: R.V. Denisova, et al.
Published: (2009-01-01)

QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α
by: R.V. Denisova, et al.
Published: (2009-05-01)

EXPERIENCE OF ADMINISTRATION OF SOLUBLE RECEPTORS TO TNF-α IN PATIENT WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
by: T.M. Bzarova, et al.
Published: (2010-01-01)

EXPERIENCE OF ADMINISTRATION OF SOLUBLE RECEPTORS TO TNF-α IN PATIENT WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
by: T.M. Bzarova, et al.
Published: (2010-05-01)

ASPECTS OF TREATMENT OF JUVENILE ARTHRITIS WITH SOLUBLE RECEPTORS TO TNF
by: E.I. Alexeeva, et al.
Published: (2008-10-01)

ASPECTS OF TREATMENT OF JUVENILE ARTHRITIS WITH SOLUBLE RECEPTORS TO TNF
by: E.I. Alexeeva, et al.
Published: (2008-01-01)

THE EXPERIENCE OF SWITCHING TO THE SECOND TNF INHIBITOR IN A PATIENT WITH SEVERE JUVENILE POLYARTHRITIS AND RESISTANCE TO THE FIRST TNF-BLOCKER
by: Ekaterina I. Alexeeva, et al.
Published: (2017-09-01)

GOLIMUMAB — A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS
by: R. V. Denisova, et al.
Published: (2012-07-01)

INFLUENCE OF IMMUNOSUPPRESSIVE AND GENETICALLY ENGINEERED THERAPY WITH TNF –alpha INHIBITOR INFLIXIMAB ON MINERAL DENSITY OF BONE TISSUE IN PATIENTS WITH JUVENILE ARTHRITIS
by: A.O. Lisitsyn, et al.
Published: (2010-01-01)

INFLUENCE OF IMMUNOSUPPRESSIVE AND GENETICALLY ENGINEERED THERAPY WITH TNF –alpha INHIBITOR INFLIXIMAB ON MINERAL DENSITY OF BONE TISSUE IN PATIENTS WITH JUVENILE ARTHRITIS
by: A.O. Lisitsyn, et al.
Published: (2010-07-01)

HUMAN MONOCLONAL ANTIBODIES TO TNF: NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC SPONDYLITIS
by: R.V. Denisova, et al.
Published: (2011-05-01)

HUMAN MONOCLONAL ANTIBODIES TO TNF: NEW OPPORTUNITIES IN TREATMENT OF JUVENILE IDIOPATHIC SPONDYLITIS
by: R.V. Denisova, et al.
Published: (2011-01-01)

Switching to a Second TNF-α Inhibitor in a Patient with Severe Juvenile Polyarthritis: A Clinical Case
by: Ekaterina V. Denisova, et al.
Published: (2018-10-01)

ANTI-TNF THERAPY PERSPECTIVES IN RHEUMATOLOGIC PRACTICE
by: E.I. Alexeeva, et al.
Published: (2008-01-01)

ANTI-TNF THERAPY PERSPECTIVES IN RHEUMATOLOGIC PRACTICE
by: E.I. Alexeeva, et al.
Published: (2008-01-01)

INTERNATIONAL PRACTICE OF ABATACEPT USE IN TREATMENT OF REFRACTORY UVEITIS IN PATIENTS WITH IDIOPATHIC JUVENILE ARTHRITIS
by: R.V. Denisova, et al.
Published: (2011-01-01)

INTERNATIONAL PRACTICE OF ABATACEPT USE IN TREATMENT OF REFRACTORY UVEITIS IN PATIENTS WITH IDIOPATHIC JUVENILE ARTHRITIS
by: R.V. Denisova, et al.
Published: (2011-09-01)

Level of shadow economy in Ukraine: reasons and ways to overcome
by: Alina Bukhtiarova, et al.
Published: (2018-05-01)

EFFICACY OF RECURRENT TREATMENT WITH RITUXIMAB IN PATIENT WITH SEVERE REFRACTORY SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS
by: S.I. Valieva, et al.
Published: (2009-11-01)

EFFICACY OF RECURRENT TREATMENT WITH RITUXIMAB IN PATIENT WITH SEVERE REFRACTORY SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS
by: S.I. Valieva, et al.
Published: (2009-01-01)

HYPOCHOLESTEROLEMIA IN SEPTIC CONDITIONS. MECHANISMS OF DEVELOPMENT AND WAYS OF CORRECTION
by: Karolina R. Grigor’eva, et al.
Published: (2023-12-01)

The perception of reasons of relapse among drug addicts: ways to overcome
by: Mohamad, Mardiana, et al.
Published: (2011)

EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB
by: E. I. Alexeeva, et al.
Published: (2012-11-01)

TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinomaResearch in context
by: Wenliang Tan, et al.
Published: (2019-02-01)

Response of pediatric uveitis to TNFα inhibitors
by: Lerman Melissa A, et al.
Published: (2012-07-01)

HUMAN MONOCLONAL ANTIBODIES TO TNF-? — AGENT OF CHOICE IN TREATMENT OF SEVERE JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsyn, et al.
Published: (2010-01-01)

HUMAN MONOCLONAL ANTIBODIES TO TNF-? — AGENT OF CHOICE IN TREATMENT OF SEVERE JUVENILE RHEUMATOID ARTHRITIS WITH UVEITIS
by: A.O. Lisitsyn, et al.
Published: (2010-05-01)

The treatment of recurrent uveitis with TNFα inhibitors
by: P.C.F. Falappone, et al.
Published: (2004-09-01)

TNF-α inhibitors in the treatment of hidradenitis suppurativa
by: Kevin T. Savage, et al.
Published: (2019-05-01)

Switching TNFα inhibitors: Patterns and determinants
by: Rosanne W. Meijboom, et al.
Published: (2021-08-01)

Bureaucratism as a phenomenon of rational bureaucracy: the reasons of appearance and the ways of overcoming
by: V. D. Bodnarchuk
Published: (2016-03-01)

Frequency of hyperglycemia and polymorphism of TNF and TP53 genes in patients with acute pancreatitis, chronic pancreatitis, pancreatic cancer
by: I. N. Grigor’eva, et al.
Published: (2022-02-01)

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
by: Dan-in Jang, et al.
Published: (2021-03-01)

Resistance to drug treatment of acromegaly and ways to overcome it
by: O. O. Golounina, et al.
Published: (2021-07-01)

Primary and secondary immune checkpoint inhibitors resistance in colorectal cancer: Key mechanisms and ways to overcome resistance
by: Hassan Abushukair, et al.
Published: (2022-01-01)

EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2009-01-01)

EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2009-07-01)

Differential impacts of TNFα inhibitors on the transcriptome of Th cells
by: Ching-Huang Ho, et al.
Published: (2021-07-01)

Positive experience with TNF-α inhibitor in toxic epidermal necrolysis resistant to high-dose systemic corticosteroids
by: Ekaterina A. Nikitina, et al.
Published: (2023-07-01)